Cite
MLA Citation
Andrew M. Kaunitz et al.. “17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial.” Menopause, vol. 27, no. 12, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100154971469.0x000007